Blood Cancer Treatments: Current and Future
Therapeutic Areas, hemato-oncology, Syndicated Studies, Oncology
Despite being considered as rare diseases, blood cancers account for 8% of all cancers and mainly...
AplusA
AplusA / Ifop Group Acquires Sociovision
To “master a changing world”, Sociovision developed a unique expertise in the monitoring of...
AplusA and Bell Falla merge forces in the US
AplusA and Bell Falla merge forces in the US to become a leading market research agency dedicated...